.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Teva
Novartis
AstraZeneca
Chubb
UBS
Argus Health
Moodys
Fish and Richardson
Colorcon

Generated: December 13, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021009

« Back to Dashboard

NDA 021009 describes ALOCRIL, which is a drug marketed by Allergan and is included in one NDA. It is available from one supplier. Additional details are available on the ALOCRIL profile page.

The generic ingredient in ALOCRIL is nedocromil sodium. There are three drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the nedocromil sodium profile page.

Summary for 021009

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Therapeutic Class:Ophthalmic Agents
Respiratory Tract Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 021009

Physiological EffectDecreased Histamine Release

Medical Subject Heading (MeSH) Categories for 021009

Suppliers and Packaging for NDA: 021009

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ALOCRIL nedocromil sodium SOLUTION/DROPS;OPHTHALMIC 021009 NDA Allergan, Inc. 0023-8842 0023-8842-05 1 BOTTLE, DROPPER in 1 CARTON (0023-8842-05) > 5 mL in 1 BOTTLE, DROPPER

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION/DROPS;OPHTHALMICStrength2%
Approval Date:Dec 8, 1999TE:ATRLD:Yes

Expired Orange Book Patents for NDA: 021009

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
AllerganALOCRILnedocromil sodiumSOLUTION/DROPS;OPHTHALMIC021009-001Dec 8, 1999► Subscribe► Subscribe
AllerganALOCRILnedocromil sodiumSOLUTION/DROPS;OPHTHALMIC021009-001Dec 8, 1999► Subscribe► Subscribe
AllerganALOCRILnedocromil sodiumSOLUTION/DROPS;OPHTHALMIC021009-001Dec 8, 1999► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

McKesson
Chinese Patent Office
Moodys
Cipla
Fuji
Colorcon
Argus Health
Cantor Fitzgerald
Johnson and Johnson
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot